OPRX - OptimizeRx Corporation (OPRX) Q4 2023 Earnings Call Transcript
2024-03-28 11:20:24 ET
OptimizeRx Corporation (OPRX)
Q4 2023 Earnings Conference Call
March 28, 2024, 08:30 AM ET
Company Participants
William Febbo - CEO
Edward Stelmakh - Chief Financial and Operating Officer
Steve Silvestro - Chief Commercial Office
Conference Call Participants
Sean Dodge - RBC Capital Markets
Stephanie Davis - Barclays
William Wood - B. Riley Securities
Presentation
Operator
Good morning, everyone and thank you for joining OptimizeRx’s Fourth Quarter Fiscal 2023 Conference Call. With us today is the Chief Executive Officer of OptimizeRx, William Febbo. He is joined by Chief Financial Officer, Ed Stelmakh; President Steve Silvestro; General Counsel Marion Odence-Ford; and Senior Vice President of Corporate Finance, Andrew D’Silva.
At the conclusion of today’s earnings call, I will provide some important cautions regarding the forward-looking statements made by management during today’s call. I would like to remind everyone that today’s call is being recorded and will be made available for replay via webcast. And a transcript and a link to the audio recording of this conference call, will be provided on the Investors section of the company’s website.
Now I would like to turn the call over to OptimizeRx CEO, William Febbo. Sir, please go ahead....
OptimizeRx Corporation (OPRX) Q4 2023 Earnings Call Transcript